Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Karolinska Development names new CEO

This article was originally published in Scrip

Executive Summary

The Swedish investment company, Karolinska Development, has appointed Torbjorn Bjerke as its new CEO. He will replace Conny Bogentoft, who will become the company's chief scientific officer and with responsibility for the future development of the company's portfolio. Mr Bjerke will assume his new position once a successor for his current role – CEO of the Swedish firm Orexo – has been named. Karolinska Development, which began operations in 2003, now has a portfolio of 45 companies, which span across several therapeutic areas, and 21 potential first-in-class products.


Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts